Targeted oral therapy for the treatment of adults with advanced basal cell carcinoma who are not appropriate surgical candidates.
Emerging Technology Reports
The Emerging Technology Report provides regular updates about emerging and potentially disruptive technologies that are likely to have a significant impact in healthcare. This “early warning” report monitors new health technologies from 6 months to 2 years within a regulatory submission and tracks those as they go through clinical trial development and the regulatory approval process.
For each emerging technology, our analysts describe the technology and intended use, its prospects relative to the regulatory process and FDA information, competing technologies, relevant clinical guidelines, high-level look at the evidence such as published abstracts in the medical literature and available meeting abstracts, and available clinical trials.
Pixuvri® (Pixantrone Dimaleate)
An intravenous single agent for third-line treatment of non-Hodgkin’s lymphoma.
EkoSonic® SV Endovascular System
A neurovascular microcatheter with an ultrasonic transducer at the tip that combines intra-arterial delivery of tissue plasminogen activator with ultrasound-accelerated thrombolysis for treatment of acute ischemic stroke.
Positron Emission Tomography / Magnetic Resonance Imaging Systems
A hybrid imaging system that allows positron emission tomography and magnetic resonance imaging to be performed in one examination session.
Spiration IBV® Valve System
Endoscopically implanted one-way valves used as an alternative to lung volume reduction surgery for palliative treatment of heterogeneous emphysema.
Melody® Transcatheter Pulmonary Valve
A percutaneously implanted device used to prolong the life span of failing prosthetic pulmonary conduits in patients with congenital heart defects.
Xarelto® (Rivaroxaban) for the Prevention of Stroke in Patients with Atrial Fibrillation
An oral factor Xa direct inhibitor for the prevention of stroke in patients with nonvalvular atrial fibrillation.
Xarelto® (Rivaroxaban) for Prevention of Venous Thromboembolism (VTE) Following Total Hip or Knee Replacement
An oral factor Xa direct inhibitor for prevention of VTE following hip or knee surgery.
MelaFind®
A computer-controlled multispectral dermoscope for detection of early pigmented cutaneous melanoma.
Exparel™ (DepoBupivacaine)
A long-acting, single-dose injectable analgesic to improve postoperative pain management. Exparel is contraindicated in obstetrical paracervical block.